Sign in
Taking people in United StatesNo phase

AI heart tracing tests to spot aortic stenosis and diastolic dysfunction in clinic patients

Tests AI-reading of heart tracings for aortic stenosis and diastolic dysfunction in outpatients.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
Status
Recruiting
People taking part
2,000 people, planned
Started
8 Nov 2024
Expected to end
Mar 2027
Type of study
Observational
Treatments tested
  • AI-ECG Dashboard
  • Point of care ultrasound (POCUS)
Record updated
4 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 60 or older who already have an ECG (heart tracing) scheduled as part of their outpatient care. An AI tool reads the ECG to look for aortic stenosis (a narrowed heart valve) and diastolic dysfunction (a stiff heart that fills poorly). People with a positive AI result then get a quick bedside ultrasound.

Age
60 years or older
Sex
All sexes

Main reasons for not taking part

  • Younger than 59 years
  • Not scheduled for a clinical ECG
  • Unable to give consent

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • ≥ 60 years of age must have a clinical scheduled ECG performed

Who cannot take part

  • < 59 years of age
  • Is not scheduled for a clinical ECG
  • Unable to provide consent

Where in United States

  • Mayo ClinicRochester, United StatesContact: Jae Oh, M.D.Taking people

About the trial

What the trial wants to find out

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

The group in the trial

  • Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

    Treatment: AI-ECG Dashboard and Point of care ultrasound (POCUS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Clinical Utility of Artificial Intelligence-enabled Electrocardiograms in the Outpatient Practice - Diagnosing Aortic Stenosis and Diastolic Dysfunction
Plain-language title
AI heart tracing tests to spot aortic stenosis and diastolic dysfunction in clinic patientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 March 2026